Literature DB >> 19522271

[Anesthetic management of pediatric patients with insulinoma using continuous glucose monitoring].

Motoko Manabe1, Hiroshi Morimatsu, Moritoki Egi, Satoshi Suzuki, Ryuji Kaku, Masaki Matsumi, Kiyoshi Morita.   

Abstract

Insulinomas are rare tumors, the incidence of which is 1-2 per million. Patients with insulinomas present with symptoms of hypoglycemia secondary to insulin hypersecretion. Surgical resection is a treatment of choice and offers the only chance of cure. The important points in anesthesia are the precaution against hypoglycemia until tumor resection and the control of rebound hyperglycemia soon after tumor resection. We report the anesthetic management of a 5-year-old patient with insulinoma. Soon after the induction of anesthesia, the continuous glucose monitoring was commenced. Until the tumor resection, 10% glucose infusion was required to avoid hypoglycemia. Then, insulin infusion was continued to maintain blood glucose level around 150 mg x dl(-1). All glucose management was guided with continuous glucose monitoring. This is a first case report to show the feasibility and usefulness of continuous glucose monitoring in management of pediatric insulinoma patients. As the blood glucose was dramatically altered during perioperative period, frequent blood glucose measurements or continuous glucose monitoring is mandatory during perioperative period of insulinoma resection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19522271

Source DB:  PubMed          Journal:  Masui        ISSN: 0021-4892


  2 in total

1.  Experience with intraoperative use of artificial pancreas during local resection of insulinoma.

Authors:  Yukio Asano; Hiroyuki Kato; Satoshi Arakawa; Masahiro Ito; Masahiro Shimura; Daisuke Koike; Chihiro Hayashi; Toki Kawai; Takahiko Higashiguchi; Akihiko Horiguchi
Journal:  Clin J Gastroenterol       Date:  2022-08-15

2.  Insulinoma and anaesthetic implications.

Authors:  Jyotsna Goswami; Pallavi Somkuwar; Yogesh Naik
Journal:  Indian J Anaesth       Date:  2012-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.